151 related articles for article (PubMed ID: 15800919)
21. Twelve-month self-reported quality of life after retropubic radical prostatectomy: a prospective study with Rand 36-Item Health Survey (Short Form-36).
Ficarra V; Novara G; Galfano A; Stringari C; Baldassarre R; Cavalleri S; Artibani W
BJU Int; 2006 Feb; 97(2):274-8. PubMed ID: 16430628
[TBL] [Abstract][Full Text] [Related]
22. Defining sexual outcomes after treatment for localized prostate carcinoma.
Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
[TBL] [Abstract][Full Text] [Related]
23. A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.
Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
Jpn J Clin Oncol; 2008 Jul; 38(7):480-5. PubMed ID: 18621847
[TBL] [Abstract][Full Text] [Related]
24. Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE.
Arredondo SA; Elkin EP; Marr PL; Latini DM; DuChane J; Litwin MS; Carroll PR;
Urology; 2006 Mar; 67(3):559-65. PubMed ID: 16527580
[TBL] [Abstract][Full Text] [Related]
25. Five-year longitudinal effect of radical perineal prostatectomy on health-related quality of life in Japanese men, using general and disease-specific measures.
Inoue S; Shiina H; Hiraoka T; Wake K; Sumura M; Honda S; Urakami S; Igawa M; Usui T
BJU Int; 2009 Oct; 104(8):1077-84. PubMed ID: 19338553
[TBL] [Abstract][Full Text] [Related]
26. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
[TBL] [Abstract][Full Text] [Related]
27. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study.
Namiki S; Satoh T; Baba S; Ishiyama H; Hayakawa K; Saito S; Arai Y
Urology; 2006 Dec; 68(6):1230-6. PubMed ID: 17141839
[TBL] [Abstract][Full Text] [Related]
28. Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?
Korfage IJ; de Koning HJ; Habbema JD; Schröder FH; Essink-Bot ML
BJU Int; 2007 Apr; 99(4):801-6. PubMed ID: 17233804
[TBL] [Abstract][Full Text] [Related]
29. The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
Karakiewicz PI; Bhojani N; Neugut A; Shariat SF; Jeldres C; Graefen M; Perrotte P; Peloquin F; Kattan MW
J Sex Med; 2008 Apr; 5(4):919-927. PubMed ID: 18371045
[TBL] [Abstract][Full Text] [Related]
30. Long-term quality of life after radical prostatectomy: 8-year longitudinal study in Japan.
Namiki S; Kaiho Y; Mitsuzuka K; Saito H; Yamada S; Nakagawa H; Ito A; Arai Y
Int J Urol; 2014 Dec; 21(12):1220-6. PubMed ID: 25143229
[TBL] [Abstract][Full Text] [Related]
31. Partnership and outcomes in men with prostate cancer.
Bergman J; Gore JL; Saigal CS; Kwan L; Litwin MS
Cancer; 2009 Oct; 115(20):4688-94. PubMed ID: 19626653
[TBL] [Abstract][Full Text] [Related]
32. Health related quality of life and direct medical care cost in newly diagnosed younger men with prostate cancer.
Jayadevappa R; Bloom BS; Chhatre S; Fomberstein KM; Wein AJ; Malkowicz SB
J Urol; 2005 Sep; 174(3):1059-64; discussion 1064. PubMed ID: 16094058
[TBL] [Abstract][Full Text] [Related]
33. Quality-of-life outcomes for men with prostate carcinoma detected by screening.
Smith DS; Carvalhal GF; Schneider K; Krygiel J; Yan Y; Catalona WJ
Cancer; 2000 Mar; 88(6):1454-63. PubMed ID: 10717630
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.
Miller DC; Sanda MG; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin WP; Wei JT
J Clin Oncol; 2005 Apr; 23(12):2772-80. PubMed ID: 15837992
[TBL] [Abstract][Full Text] [Related]
35. Age and baseline quality of life at radical prostatectomy--who has the most to lose?
Brajtbord JS; Punnen S; Cowan JE; Welty CJ; Carroll PR
J Urol; 2014 Aug; 192(2):396-401. PubMed ID: 24582539
[TBL] [Abstract][Full Text] [Related]
36. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate.
Walsh PC
J Urol; 2000 Jun; 163(6):1802-7. PubMed ID: 10799186
[TBL] [Abstract][Full Text] [Related]
37. Disease-specific quality of life among patients with localized prostate cancer: an Australian perspective.
Newton FJ; Burney S; Millar JL; Frydenberg M; Ng KT
BJU Int; 2006 Jun; 97(6):1179-83. PubMed ID: 16686708
[TBL] [Abstract][Full Text] [Related]
38. Promising long-term health-related quality of life after high-dose-rate brachytherapy boost for localized prostate cancer.
Wahlgren T; Nilsson S; Lennernäs B; Brandberg Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):662-70. PubMed ID: 17499452
[TBL] [Abstract][Full Text] [Related]
39. Health-related quality of life evaluation in patients undergoing cavernous nerve reconstruction during radical prostatectomy.
Sugimoto M; Tsunemori H; Kakehi Y
Jpn J Clin Oncol; 2009 Oct; 39(10):671-6. PubMed ID: 19654133
[TBL] [Abstract][Full Text] [Related]
40. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.
Sanderson KM; Penson DF; Cai J; Groshen S; Stein JP; Lieskovsky G; Skinner DG
J Urol; 2006 Nov; 176(5):2025-31; discussion 2031-2. PubMed ID: 17070244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
